A new drug for pancreatic cancer, one of the deadliest cancers, saw patients live almost double the time compared to those treated with chemotherapy in a clinical trial.
A new drug for pancreatic cancer, one of the deadliest cancers, saw patients live almost double the time compared to those treated with chemotherapy in a clinical trial.
